KEYNOTE-365 cohort c updated results: Pembrolizumab (pembro) plus enzalutamide (enza) in abiraterone (abi)-pretreated patients with metastatic Castration-Resistant Prostate Cancer (mCRPC)

• S. Feyerabend,
• W. Berry,
• P. Fong,
• J.M. Piulats,
• L. Appleman,
• H. Conter,
• N. Shore,
• G. Gravis,
• B. Laguerre,
• H. Gurney,
• M. Retz,
• E. Romano,
• L. Mourey,
• J. De Bono,
• A. Kam,
• U. Emmenegger,
• H. Wu,
• C. Schloss,
• C. Poehlein,
• E.Y. Yu

Affiliations

S. Feyerabend

W. Berry

P. Fong

J.M. Piulats

L. Appleman

H. Conter

N. Shore

G. Gravis

B. Laguerre

H. Gurney

M. Retz

E. Romano

L. Mourey

J. De Bono

A. Kam

U. Emmenegger

H. Wu

C. Schloss

C. Poehlein

E.Y. Yu